Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Leveraging diet to engineer the gut microbiome
Mathis Wolter, Erica T. Grant, Marie Boudaud, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 885-902
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 247
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Eiji Miyauchi, Chikako Shimokawa, Alex Steimle, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 1, pp. 9-23
Closed Access | Times Cited: 206
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 166
The gut microbiome and hypertension
Joanne A. O’Donnell, Tenghao Zheng, Guillaume Méric, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 153-167
Closed Access | Times Cited: 121
Gut microbiota: A new insight into lung diseases
Peijun Ma, Mengmeng Wang, Yun Wang
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113810-113810
Open Access | Times Cited: 72
Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease
Yuji Pu, Fan Xi, Zhuangzhuang Zhang, et al.
Journal of Controlled Release (2022) Vol. 354, pp. 1-18
Closed Access | Times Cited: 69
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 49
Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility
Mathis Wolter, Erica T. Grant, Marie Boudaud, et al.
Molecular Systems Biology (2024) Vol. 20, Iss. 6, pp. 596-625
Open Access | Times Cited: 15
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 12
Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodelling
Jianlong Yan, Yanbin Pan, Wenming Shao, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 58
Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability
Guilherme Ramos Meyers, Hanen Samouda, Torsten Bohn
Nutrients (2022) Vol. 14, Iss. 24, pp. 5361-5361
Open Access | Times Cited: 53
What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?
Josie van Dorst, Rachel Y. Tam, Chee Y. Ooi
Nutrients (2022) Vol. 14, Iss. 3, pp. 480-480
Open Access | Times Cited: 42
The Potential of Honey as a Prebiotic Food to Re-engineer the Gut Microbiome Toward a Healthy State
Kathleen R. Schell, Kenya E. Fernandes, Erin R. Shanahan, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 40
Engineering the gut microbiome
Xiaowu Bai, Ziyu Huang, Anna Duraj‐Thatte, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 9, pp. 665-679
Closed Access | Times Cited: 27
Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer’s Disease
Guangsu Zhu, Jianxin Zhao, Hao Zhang, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 4, pp. 819-839
Open Access | Times Cited: 25
An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease
Zhuangzhuang Zhang, Yang Pan, Zhaoyuan Guo, et al.
Bioactive Materials (2023) Vol. 33, pp. 71-84
Open Access | Times Cited: 22
Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
Yuan Zeng, Yifan Wu, Qian Zhang, et al.
mBio (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 20
The interaction between Mediterranean diet and intestinal microbiome: relevance for preventive strategies against frailty in older individuals
Andrea Ticinesi, Antonio Nouvenne, Nicoletta Cerundolo, et al.
Aging Clinical and Experimental Research (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 9
Semiconducting polymer dots for multifunctional integrated nanomedicine carriers
Ze Zhang, Chenhao Yu, Yuyang Wu, et al.
Materials Today Bio (2024) Vol. 26, pp. 101028-101028
Open Access | Times Cited: 8
The gut microbiota derived metabolite trimethylamine N-oxide: Its important role in cancer and other diseases
Yuhua Zhou, Yuwei Zhang, Shengkai Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117031-117031
Open Access | Times Cited: 8
Gut microbiota and their metabolites in the immune response of rheumatoid arthritis: Therapeutic potential and future directions
Xiaoyu Cai, Fujia Ren, Yao Yao
International Immunopharmacology (2025) Vol. 147, pp. 114034-114034
Closed Access
Intra-tumoral bacteria in breast cancer and intervention strategies
Ting Hou, Xiaoling Huang, Jiahui Lai, et al.
Advanced Drug Delivery Reviews (2025), pp. 115516-115516
Closed Access
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Systemic inflammation is associated with gut microbiota diversity in post-stroke patients
Yoshihiro Yoshimura, Hidetaka Wakabayashi, Fumihiko Nagano, et al.
European Geriatric Medicine (2025)
Closed Access
Alleviation of DSS-induced colitis by Meconopsis polysaccharides correlated with reduced PI3K/AKT signaling and gut microbiome diversity
Jun Dai, Weidong Wang, Fangfang He, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top